Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives Cagrilintide Dosage and Weight Loss Guide PEP DOSE Updates in Medicine REDEFINE 2: CagriSema in T2D + Obesity Original article link in bio Phase 3a RCT in 1206 adults with T2D (BMI 27, HbA1c 710%) Instagram Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3 eBioMedicine Let me introduce you to a NEW peptide : Cagrilintide is an amylin analog which is now being developed in combination with GLP 1 agonist Semaglutide to achieve sustained